retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity There's a new drug going viral on social media called Retatrutide. It's currently in Stage 3 of clinical trials and not yet licensed anywhere in the world, but that's not stopped people From Obesity to Metabolic Health:

It is important to consider potential variations in efficacy among subjects and potential differences in potency compared to injectable formulations

Gastrointestinal protection: BPC-157 was originally discovered in gastric juice and has been shown to protect the gastrointestinal tract from damage caused by various agents, such as NSAIDs (nonsteroidal anti-inflammatory drugs), alcohol, and stress

Semaglutide and tirzepatide are GLP-1 receptor agonists (tirzepatide also targeting GIP), mimicking gut hormones that regulate satiety and blood sugar a well-established pathway with extensive human data

Some foods can help regulate thyroid function, while others may exacerbate symptoms

Complimentary Skin Analysis Offer To kickstart your journey, were offering a complimentary skin analysis